Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
Uthman
Imad
I
Department of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon.
Taher
Ali
A
Abbas
Ossama
O
Menassa
Janine
J
Ghosn
Samer
S
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy* / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D000069283:Rituximab; D012867:Skin / Q000473:pathology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007155:Immunologic Factors; D000069283:Rituximab